As JPM 2024 winds down, some health tech firms project optimism

AdobeYou’rereadingthewebeditionofSTAT’sHealthTechnewsletter,ourguidetohowtechnologyistransformingthe MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar




knowledge

author:comprehensive    Page View:1151

Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.

STAT’s reporters, strung-out from several days of ASCO madness, will take the virtual stage to share convention hall insights, predictions for the months ahead, and of course will take your audience questions live.

advertisement

Sponsor Introduction

  • Ashwin Athri, EVP, strategy, innovation, & partnerships, Precision AQ

Featured Speakers

  • Angus Chen, cancer reporter, STAT
  • Adam Feuerstein, senior writer, biotech, STAT
  • Matthew Herper, senior writer, medicine; editorial director of events, STAT
  • Katherine MacPhail, programmer, editorial events, STAT (moderator)

Sponsored By